This program supports the creation of a prototype Open Knowledge Network — an interconnected network of knowledge graphs supporting a very broad range of application domains. Open access to shared ...
PRINCETON, NJ, and OKLAHOMA CITY, OK--(Marketwired - February 15, 2016) - GtreeBNT Co., Ltd., has entered into an agreement with the Oklahoma Medical Research Foundation (OMRF) to acquire the rights ...
Clinical outcomes of the combination of bevacizumab and ttfields in patients with recurrent glioblastoma: Results of a phase II clinical trial. This is an ASCO Meeting Abstract from the 2020 ASCO ...
OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer. Patients can now enroll in a phase 1 clinical trial ...
Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year. The Food and Drug Administration (FDA) has fast tracked an investigational therapy for diffuse ...
Below is a summary assembled by the Research & Innovation Office (RIO). Please see the full solicitation for complete information about the funding opportunity. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results